Table 1.
Basic characteristics of study participants.
| Characteristics | Subjects receiving acenocoumarol | Control subjects | p |
|---|---|---|---|
| Number, n | 58 | 35 | |
| Age, years | 65 (59; 73) | 61 (59; 72) | NS |
| Gender (male/female), n (%) | 27 (46.6)/31 (53.4) | 16 (45.7)/19 (54.3) | NS |
| Body mass index, kg/m2 | 28.1 (24.9; 31.3) | 27.3 (24.4; 29.4) | NS |
| Post-menopause, years | 15 (8.8; 23.3) | 9 (6; 23) | NS |
| Smokers/non-smokers, n (%) | 11 (19)/47 (81) | 4 (11.4)/31 (88.6) | NS |
| Duration of AC treatment, years | 8 (6.8; 12.3) | 0 | <0.001 |
| Weekly dose of AC, mg | 19 (14; 28) | 0 | <0.001 |
| Serum 25(OH)D, ng/mL | 20.4 (17.4; 26.1) | 28.2 (24; 32.7) | <0.001 |
| ALP, IU/L | 61 (54.3; 75) | 54 (51; 68) | NS |
Results are shown as median and quartiles (Q1; Q3).
To convert values for 25-hydroxyvitamin D to nmol/L, multiply by 2.5.